Efficacy and Myocardial Injury With Subcutaneous Implantable Cardioverter Defibrillators　– Computer Simulation of Defibrillation Shock Conduction

Efficacy and Myocardial Injury With Subcutaneous Implantable Cardioverter Defibrillators　– Computer Simulation of Defibrillation Shock Conduction –

Published:2016 Issue:1 Volume:80 Page:85-92
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Noro Mahito¹,Zhu Xin²,Enomoto Yoshinari¹,Asami Masako¹,Ishii Rina¹,Toyoda Yasutake¹,Sahara Naohiko¹,Takagi Takahito¹,Narabayasi Yuriko¹,Hashimoto Hikari¹,Ito Naoshi¹,Kujime Shingo¹,Oikawa Yasuhiro³,Tatsunami Hiroyuki³,Sakai Tsuyoshi⁴,Nakamura Keijirou¹,Sakata Takao¹,Sugi Kaoru¹

Affiliation:

1. Division of Cardiovascular Medicine, Toho University Ohashi Medical Center

2. Biomedical Information Technology Lab, University of Aizu

3. Boston Scientific Japan

4. Division of Cardiovascular Medicine, Saiseikai Yokohama Eastern Hospital

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.jstage.jst.go.jp/article/circj/80/1/80_CJ-15-0883/_pdf

Reference22 articles.

1. 1. Bardy GH, Smith WM, Hood MA, Crozier IG, Melton IC, Jordaens L, et al. An entirely subcutaneous implantable cardioverter-defibrillator. N Engl J Med 2010; 363: 36–44.

2. 2. Killingsworth CR, Litovsky SH, Melnick SB, Vance FL, Ideker RE, Walcott GP. Shocks delivered via a subcutaneous defibrillation system cause less acute injury than transvenous leads in swine. Heart Rhythm 2010; 7: S186.

3. 3. Satake H, Fukuda K, Sakata Y, Miyata S, Nakano M, Kondo M, et al; CHART-2 Investigators. Current status of primary prevention of sudden cardiac death with implantable cardioverter defibrillator in patients with chronic heart failure: A report from the CHART-2 Study. Circ J 2015; 79: 381–390.

4. 4. JCS Joint Working Group. Guidelines for non-pharmacotherapy of cardiac arrhythmias (JCS 2011): Digest version. Circ J 2013; 77: 249–274.

5. 5. Weiss R, Knight BP, Gold MR, Leon AR, Herre JM, Hood M, et al. Safety and efficacy of a totally subcutaneous implantable-cardioverter defibrillator. Circulation 2013; 128: 944–953.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low‐energy defibrillation using a base–apex epicardial electrode;Pacing and Clinical Electrophysiology;2023-10-13

2. Eligibility for subcutaneous implantable cardioverter-defibrillator in congenital heart disease;Heart Rhythm;2020-05

3. Eligibility for Subcutaneous Implantable Cardioverter Defibrillator in Congenital Heart Disease;2019-10-18

4. Determinants of Subcutaneous Implantable Cardioverter-Defibrillator Efficacy;JACC: Clinical Electrophysiology;2017-04

5. Right Parasternal Lead Placement Increases Eligibility for Subcutaneous Implantable Cardioverter Defibrillator Therapy in Adults With Congenital Heart Disease;Circulation Journal;2016